Comments
Loading...
OncoSec Medical Analyst Ratings and Price Targets | OTC:ONCSQ | Benzinga
OncoSec Medical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for OncoSec Medical Corp from these most-recent analyst ratings.
Analyst Ratings for OncoSec Medical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for OncoSec Medical (ONCSQ) stock?
There is no price target for OncoSec Medical
What is the most recent analyst rating for OncoSec Medical (ONCSQ)?
There is no analyst for OncoSec Medical
When was the last upgrade for OncoSec Medical (ONCSQ)?
There is no last upgrade for OncoSec Medical
When was the last downgrade for OncoSec Medical (ONCSQ)?
There is no last downgrade for OncoSec Medical.
When is the next analyst rating going to be posted or updated for OncoSec Medical (ONCSQ)?
There is no next analyst rating for OncoSec Medical.
Is the Analyst Rating OncoSec Medical (ONCSQ) correct?
There is no next analyst rating for OncoSec Medical.
Browse analyst ratings and price targets on all stocks.
